Trigeminal neuralgia: case report and literature review by Turton, Mervyn & Malan-Roux, Pieter
                                                                                             www.sdsjournal.com
Case Report Open Access




© The Author(s) 2019. Open Access This article is licensed under a Creative Commons Attribution 4.0 
International License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, 
sharing, adaptation, distribution and reproduction in any medium or format, for any purpose, even commercially, as long 
as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made.
Trigeminal neuralgia: case report and literature 
review
Mervyn Turton, Pieter Malan-Roux
Department of Community Dentistry, University of the Western Cape, Robert Sobukwe Rd, Bellville 7535, South Africa.
Correspondence to: Dr. Mervyn Turton, Department of Community Dentistry, University of the Western Cape, Robert Sobukwe 
Rd, Bellville, Cape Town 7535, South Africa. E-mail: mturton@webmail.co.za
How to cite this article: Turton M, Malan-Roux P. Trigeminal neuralgia: case report and literature review. Stomatological Dis Sci 
2019;3:7. http://dx.doi.org/10.20517/2573-0002.2019.08
Received: 1 Apr 2019    First Decision: 10 Jun 2019    Revised: 19 Jun 2019    Accepted: 1 Jul 2019    Published: 29 Jul 2019
Science Editor: Dimitrios Dionysopoulos    Copy Editor: Jia-Jia Meng    Production Editor: Jing Yu
Abstract
Trigeminal neuralgia (TN), also known as tic doloureaux, is a nerve disorder of the face and is considered to be one 
of the most painful human conditions. A 51-year-old male presented with severe intermittent pain on the left side of 
his face. Magnetic resonance image scan with contrast revealed a close association of the superior cerebella artery 
and the trigeminal nerve on the left side of the face. Oral medication is the first line of treatment for TN, because 
of its non-invasiveness, low cost and high effective rate. Surgical intervention for TN aims to relieve the pressure 
of the offending artery or vein that is compressing the trigeminal nerve or in other instances; surgery may stop the 
uncontrolled pain signals. An important criterion for clinical diagnosis is pain that cannot be attributed to another 
disorder and also the lack of evident neurologic disorder. TN is one of the most debilitating diseases an individual 
may suffer and an early astute diagnosis of TN will provide patients with relief from suffering, unnecessary dental 
and medical intervention. Appropriate and early diagnosis of TN is important to formulate an optimal management 
plan based on the patient’s age and general condition. The aim of this case report is to describe a case of Classical 
TN, and subsequent successful surgical management with microvascular decompression.
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INTRODUCTION
Trigeminal neuralgia (TN), also known as tic doloureaux[1,2], is considered to be one of the most physically 
and psychologically painful conditions a human being might suffer[1,2]. Living with TN can have a 
significant negative impact on a person’s quality of life[3], resulting in problems such as seclusion, weight 
loss and depression[3,4]. TN is caused by neurovascular conflict[1] which is compression of the trigeminal 
nerve or an underlying condition that affects this nerve[1,2].
TN causes an abrupt, searing facial pain that shoots within the distribution of one or more branches of the 
trigeminal nerve[5]. It manifests as a short-lived but intense sudden, severe, brief, stabbing, and recurrent 
pain[1,5,6].
TN is diagnosed clinically based on the history of symptoms which the patient usually describes as a 
sudden shooting or stabbing pain, which may be solitary sensations or paroxysms in between pain‐free 
intervals[3,4,6]. TN may be triggered by stimuli that are usually not painful, such as a facial caress, exposure 
to a gentle breeze, chewing, speaking, or brushing teeth may trigger TN[3,4,6]. In some cases TN may be 
preceded by facial tingling or numbness prior to the onset of pain[6]. TN in most cases affects a single 
division and it can later spread to other divisions[7], with specific areas on the face triggering pain when 
stimulated[4,5]. The attacks of pain occur more frequently and more severely with time[6,7] and may manifest 
with one or several symptoms such as intense, shooting, stabbing pain that is similar to electric shocks, 
intermittent twinges of mild pain,spasms of pain, episodes of cluster attacks. TN pain can be focused 
in a specific area or spread over a widespread area[7,8,9]. TN pain episodes can last from a few seconds to 
several minutes, usually unilaterally, or less frequently on both sides of the face. The attacks of pain may 
go into remission and patients maybe symptomless for months or years[5,7]. Women are twice as likely to be 
affected with this condition as men and in both genders, it is more prevalent after the age of 40 years[1,3], 
with a prevalence of 4.3 per 100,000[8,10].
TN is classified as classical or symptomatic TN[5,8] and symptomatic TN is caused by disease that leads to 
neural damage such as multiple sclerosis, herpes zoster, trauma, space-occupying lesion or tumours of the 
cerebellopalatine angle[2,4]. Classical TN is caused by neurovascular conflict and is divided into type 1 and 
2[1,5]. Type 1 is purely paroxysmal and the patient is has no pain in between attacks and type 2 presents 
with persistent simultaneous, background facial pain between attacks. Type 2 is also known as atypical TN 
and in this type central sensitization may be responsible for the persistent pain. Neurovascular conflict 
may not be evident in type 2, and is found to be resistant to several treatment modalities[5,6]. Classical TN 
is characterized by very severe, sudden, severe excruciating, shock-like pain paroxysms usually on one 
side of the face at the second and/or third trigeminal branch region[1,2,8]. The typical description is usually 
volunteered by the patient as a sharp shooting pain similar to having an electric shock in the jaw, teeth 
or gums[5,6,7,9]. The painusually occurs in erratic attacks which have a duration of a few seconds to about 
2 min, and these attacks stop as suddenly as they start[5,6,7,9]. TN usually manifests on one side of the face 
and the pain is usually felt in all or part of the face. TN does not usually manifest on both sides of the face, 
however if it does, it is seldom at the same time[5,7,9].
TN attacks of pain can occur on a regular basis for days, weeks or months at a time and in severe cases 
attacks may occur quite a few times a day[6,7]. TN pain may go in to remission becoming less or sometimes 
disappearing completely for several months or years at a time, thereafter it emerges more intensely[6,7,9]. 
The remission periods tend to get progressively shorter and at times develop into a more persistent aching, 
agonizing and burning sensation, which may or may not be accompanied by bouts of sharp attacks[4,6,8].
 
The aims of this case presentation is to describe a case of classical TN, and subsequent successful 
management with microvascular decompression (MVD) as appropriate and early diagnosis of this 
debilitating condition is imperative in formulating an optimal management plan.
CASE REPORT
A 51-year-old male presented with a main complaint of severe, sharp, piercing intermittent electrical-
like shock pain on the left side of his face. The pain was triggered by talking, washing his face, eating 
Page 2 of 10                                   Turton et al. Stomatological Dis Sci 2019;3:7  I  http://dx.doi.org/10.20517/2573-0002.2019.08
and brushing of his teeth and the patient VAS score was four. No pathology was detected during the intra 
and extra oral examination except clicking of the temporomandibular joint associated with opening and 
closing jaw movement. 
Patient had a history of temporomandibular joint pain previously (about 20 years ago) which was treated 
and had resolved. Radiological investigation revealed no abnormalities and the patient had no history of 
diabetes mellitus, high blood pressure, chronic heart diseases, hepatitis, or any other pertinent chronic 
diseases. A provisional diagnosis of TN was made which was confirmed by an magnetic resonance image 
(MRI) scan with contrast, which revealed a close association of the superior cerebellar artery and the 
trigeminal nerve on the left side [Figure 1].
The treatment options of medication and surgery was discussed with the patient and blood samples were 
taken from the patient for a full blood count, carbamazepine level analysis and to test liver function, which 
were found to be normal. Carbamazepine (Tegretol® 200 mg twice daily) was prescribed and the patient 
volunteered that he was pain free at the recall appointment a month later, at which time the patient was 
found to be coping and symptom free.
The same patient presented a year later with neuralgic pain which started 3 weeks prior. The patient 
reported that the episodes of pain had increased in severity and frequency, with a longer duration lasting 
several minutes and increased in intensity. The patient further reported side effects from the medications 
which were impacting negatively on his physical, social, and psychological function. Considering the 
patient’s current reduced quality of life, pain intensity and the ineffectiveness of the medication, the 
expected chance of a successful outcome of the surgical interventions was weighed against the potential 
surgical complications for the intervention. Neurosurgical treatment was recommended to the patient 
and information about the efficacy and potential complications for each type of surgical intervention was 
given by the treating neurosurgeon in the presence of a close relative, verbally and in writing. A full blood 
analysis, carbamazepine levels and liver function tests were done and found to be within normal ranges, 
thereafter baclofen (Lioresal, 5 mg three times daily) was prescribed for the patient.
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Figure 1. MRI scan with contrast which revealed close association of the superior cerebellar artery and the trigeminal nerve on the left 
side.The label of the left superior cerebellar artery points to the exact point of where the artery is in contact with the left trigeminal nerve. 




L Sup cerebellar artR Sup cerebellar art
The patient then presented two weeks later with breakthrough pain stating that the condition had become 
unresponsive to the medication and the pain had become unbearable. He further complained of being 
woken up from several times from sleep (± 5 times daily) by severe pain possibly triggered by the stimuli 
of the pillow rubbing his face when changing his sleeping position. The patient then requested the option 
of MVD procedure and three weeks later was successfully treated with MVD. The patient’s symptoms 
resolved postoperatively without complications and there has been no reports of neuralgic attacks at the 1st 
and 2nd years follow up visits.
MVD was considered to be the best surgical treatment because a neurovascular conflict was identifiable 
on the MRI and the patient was screened and found to be stable enough to undergo open neurosurgery. 
In MVD, the target area lies at the nerve-pons junction. A suboccipital craniotomy was performed to 
access the posterior fossa. The cerebrospinal f luid was aspirated and then the superolateral margin of the 
cerebellum was gently retracted to gently expose the nerve. The nerve was found to be compressed by a 
loop of the superior cerebellar artery at the root entry zone [Figure 2]. 
The arachnoid was then dissected and the vessel including the entire root, from meckel’s cave to the 
trigeminal root entry zone, was freed from all arachnoid adhesions. A piece of shredded Teflon gauze was 
placed between the vessel and the nerve to completely separate the two [Figure 3]. 
The patient’s symptoms resolved postoperatively without complications and there has been no report of 
neuralgic attacks at the last follow up visit.
DISCUSSION
According to the international guidelines[10] on TN treatment carbamazepine and oxycarbamazepine 
is recommended as first line treatment based on clinical studies[1,11,12]. Oral medication, due to its non-
invasiveness, low cost and high effective rate is the first line of treatment which involves prescribing 
anticonvulsant[12,13]. Medication in the form of analgesics (paracetamol and aspirin) and anti-inflammatory 
tablets (ibuprofen) are ineffective for TN pain[13,14]. Anticonvulsants commonly used for TN are: 
carbamazepine (Tegretol, Carbatrol, Epitol)[13,14,15], oxycarbazepine (Trileptal )[16], baclofen ( Lioresal)[17], 
gabapentin (Neurontin), valproic acid (Depakene, Depakote), phenytoin (Dilantin), topiramate (Topamax) 
and lamotrigine (Lamictal)[7,10] which have been found to be effective as various combination treatments or 
stand alone treatments for TN[11,14,15]. Common adverse effects of anticonvulsants include: nausea, dizziness, 
confusion, drowsiness, vision problems, suicidal thoughts and allergies[15,16,17].
Figure 2. Microscopic image showing superior cerebella artery compressing the trigeminal nerve
Page 4 of 10                                   Turton et al. Stomatological Dis Sci 2019;3:7  I  http://dx.doi.org/10.20517/2573-0002.2019.08
The international guidelines[10] further state that surgery would be a reasonable next step in the case where 
sodium-channel blockers (carbamazepine or oxcarbazepine) are ineffective[10,12] thus invasive treatments 
can be considered and implemented depending on the suitability of the patient for the procedure[10,12,18]. 
Surgery intervention for TN aims to relieve the pressure of the offending artery or vein from compressing 
the trigeminal nerve[15,16,17] or in other instances surgery may stop the uncontrolled pain signals by 
damaging the trigeminal nerve[12,19,20] which may also lead to temporary or permanent facial numbness[8].
There are a number of surgical options available to effectively treat TN which include percutaneous glycerol 
rhizotomy (PGR), percutaneous balloon compression (PBC), percutaneous stereotactic radiofrequency 
thermal rhizotomy (PSRTR), gamma-knife radiosurgery (GKR), partial sensory rhizotomy (PSR) and 
MVD[8,21-23].
Surgery can provide good relief, but relapse may occur within months or years later[8,20]. According to the 
literature most cases, up to 95% of cases of TN is caused by an artery or vein compressing the trigeminal 
nerve[8,20,21]. The area of pain in classical TN will depend on which of the three branches of the trigeminal 
nerve is affected, though more than one branch at a time can be affected[8,22,2]. The ophthalmic branch has 
an effect on the forehead, nose, and eyes; the maxillary branch has an effect on the lower eyelid, eyes, side 
of nose, cheek, upper gum, upper lip, and upper teeth[8,22,23]. The mandibular branch has an effect on the 
lower jaw, teeth, gum, and lip[8,22,23].
Oral medication is usually the first line of treatment of Classical TN due to its high effective rate, 
none-invasiveness and low cost[8,12]. The international guidelines[10] on TN treatment recommends 
carbamazepine[13] and oxcarbazepine[16], baclofen[17], pregabalin, lamotrigine and gabapentin[13,14] which have 
been found to be effective as various combination treatments or stand alone treatments for TN[10,24]. There 
are a number of surgical options available to effectively treat TN which include PGR, PBC, PSRTR, GKR, 
PSR and MVD[8,22,23]. 
PGR is a procedure also known as a glycerol injection, is performed under mild sedation and local 
anaesthesia. A little quantity of sterile glycerol is injected damaging the trigeminal nerve, and thus 
blocking the pain signals[8,23]. An opening at the base of the skull is accessed by inserted a needle through 
the face which is then guided by imaging techniques to the joining point of the three branches of the 
trigeminal nerve[8,23]. This procedure uses similar trajectories as in radiofrequency lesioning and balloon 
compression where the needle is inserted into the trigeminal cistern through the foramen ovale[8,23]. The 
Figure 3. Microscopic image showing the Teflon gauze in place between superior cerebellar artery and the trigeminal nerve
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majority of people experience immediate and significant pain relief with PGR, though pain may recur 
later. A common side effect of PGR is facial tingling or numbness[8,23].
PBC of the trigeminal nerve is a procedure where a hollow needle is used to place a balloon next to the 
nerve which is then inflated. In almost all the patients there is only a mild sensory loss with immediate 
pain relief [8,23].
PSRTR destroys specifically selected nerve fibres linked to pain by means of electrical currents by means 
of an electrode which is attached to the nerve root under sedation thereafter the patient awakened from 
sedation to determine whether they can feel the electrical pulses. The patient is then sedated again and 
the nerve is destroyed by heating the electrodes[8,19]. A common side effect of PSRTR will experience some 
facial numbness afterward[19]. 
GKR is a technique that aims a high dose of radiation at the root of the trigeminal nerve, gradually 
resulting in damage to the nerve. Pain relief will gradually take place over several weeks however the initial 
pain relief may take a few weeks to effect. Most patients are successfully treated with GKR though some 
patients may experience a relapse[21,22]. 
PSR entails making a perforation in the skull and the nerve is severed or at times rubbed, which results in 
the patient having permanent facial numbness.
MVD is a surgical procedure that entails placing Tef lon gauze between the nerve and any offending 
arteries or veins, effectively separating them away from the nerve[25,26]. MVD is a safe and effective 
procedure due to developments in surgical techniques,use of operation microscope and advances in 
neuro anaesthesia[26,27,28]. In MVD, the posterior fossa is approached through a suboccipital craniotomy to 
access the target area at the nerve-pons junction[26,27,28]. The cerebrospinal f luid is aspirated, then operator 
advances toward the nerve by gently retracting the superolateral margin of the cerebellum[26,27,28]. The 
offending vessel is usually the superior cerebellar artery and less frequently, the anterior inferior cerebellar 
artery or the superior petrosal veins which compress the nerve at the root entry zone[20,22,26]. The arachnoid 
is then dissected and the vessel freed, then the surgeon inserts a piece of shredded Teflon gauze between 
the offending vessel and the nerve to separate them[26,27,28].
MVD can be performed on patients of any age provided the patient is screened and found to be stable 
enough to undergo general anaesthesia. Retrospective studies showed that pain relief and complications were 
not age dependant[8,26,29,30] as in this case, most patients (87%-98%) experienced immediate pain relief[20,29,30] 
the initial success rate of 85 to 95% with a recurrence rate of 20% and 30%, at 6 and 10 years[23,29,30]. Though 
results from definite arterial compression are better, a recurrence rate of 31% has been reported usually 
occurring within the first 12 months of the operation in patients with TN caused by venous compression. 
In cases of recurrence, re‐exploration and neuroablative procedures have been recommended for remedial 
action[26,29,30]. MVD is not associated with any sensory loss[29], however reported complications are eighth 
nerve injury in 0.8%, cerebellar injury was reported in 0.45%, and cerebrospinal f luid leak in 1.85%[8,29,30]. It 
is imperative that patients should be monitored postoperatively to screen for complications such as corneal 
abrasions and anaesthesia dolorosa[8,29,30].
Pharmacotherapy with anti convulsants such as oxycarbamazepine or phenytoin is worth trying in the first 
instance as the initial therapyand is often sufficient and effective for 75% of patients[3,5,21]. Invasive surgery 
procedures is thus a consideration if pharmacologic treatment fails and the patient is a good candidate for 
surgery[3,5,21]. TN is a chronic condition that requires long term monitoring and when pharmacotherapy 
therapy is instituted,a full blood analysis, carbamazepine levels and liver function tests are required[12,13] 
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prior to commencement for a baseline. On commencement of the treatment full liver function and 
carbamazepine levels should be monitored closely, that is after the first two weeks and then every three 
months[13,14,15] and whenever the dose is adjusted or adverse effects appear, and annually thereafter[13].
Oxcarbazepine has fewer side effects, but it can cause hyponatremia, thus necessitating monitoring with 
serial serum sodium measurements in the first few weeks after initiating therapy[14,15]. The option of 
increasing the dosage of the medication, or the addition of a second anticonvulsant medication, should 
be considered in patients who experience breakthrough pain[17]. In cases where the patients are young 
(< 60 years at onset) or patient becomes non responsive to medication, early neurosurgical treatment 
should be considered, regardless of a negative brain MRI[3,4,21]. Holistic, individualised care is imperative 
when considering neurosurgery[4,5,21] as surgery that can provide complete relief for many years, if not 
permanently, excluding the need for anticonvulsant medications and excludes the impact of medication 
side effects[26,27]. 
 
Trigeminal nerve compression will not always present with pain symptoms and it has been suggested that 
in the symptomatic cases, the pressure on the nerve causes demyelination which is the wearing away of the 
protective outer layer referred to as the myelin sheath[7,20,21]. This demyelination causes uncontrollable pain 
signals to manifest along the nerve, though this fails to adequately explain why asymptomatic remission 
can occur and why there is immediate pain relief post operatively after removal of a blood vessel away from 
the nerve[20,21,30]. Management of TN must be tailored individually, early diagnosis and prompt referral 
for specialised care is thus imperative[8,12,22]. A lack of efficacy or intolerable side effects to oral medication 
justifies the recommendation of neurosurgical treatment to the patient[12,22]. The patient must be educated 
of the relative efficacy of various modalities of treatments, including complications and recurrence 
rates[12,23,24]. In this case the expected benefits of surgery outweighed the risks, given the patient’s quality of 
life, pain intensity and side effects with respect to physical, social and psychological functions. The results 
of the MRI scan which indicated neurovascular contact and the efficacy and potential complications of 
neurosurgery were explained and discussed with the patient. Given there was no contra indication to open 
neurosurgery, MVD was the choice of surgical treatment in anticipation of a permanent cure.
According to The International Headache Society clinical criteria for TN diagnosis[10], a diagnosis of TN 
can be made when at least three attacks of unilateral facial pain occur fulfilling these criteria: 
•	attacks occurring in one or more divisions of the trigeminal nerve, with no spread of pain beyond the 
trigeminal distribution and;
•	pain with at least three of the following four characteristics: 
(1) electric-like, shocking, piecing in characteristic; 
(2) severe intensity; 
(3) recurring attacks of a paroxysmal nature, a fraction of a second to 2 min duration; and
(4) precipitated by innocuous stimuli to the affected side of the face[10]. 
A decisive factor in the clinical diagnosis is pain that cannot be ascribed to another condition and also 
the lack of evident neurologic disorder[3,11,21]. An MRI of the brain plays an significant role in the diagnosis 
and presurgical evaluation of TN, especially in assisting in identification of the cause of TN, such as the 
neurovascular conflict or secondary causes of TN[11,21]. The list of differential diagnoses includes a number 
of other causes of orofacial pain and headaches such as tumours (meningiomas, acousticneuromas), 
headache disorders (cluster headache, trigeminal autonomic cephalalgia), dental pain (fractured 
tooth, dental infection), tempo-mandibular joint disorders, eyes, nose (sinusitis) and other neuralgias 
(glossopharyngeal, occipital and post-herpetic), and atypical facial pain[3,11,21]. The diagnosis of TN is 
almost entirely based on the patient’s history and as in most cases of facial pain, no specific laboratory 
tests are needed, and other possible diagnosis are eliminated after taking a good history and clinical 
examination[4,5,21].
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Classical TN is in most instances diagnosed on the basis of typical history and clinical features however, 
vascular compression is usually identified with high-resolution MRI[11,21] which is also useful to detect 
any secondary causes like multiple sclerosis or tumours. Preoperative magnetic resonance tomographic 
angiography is recommended as useful in patient selection and prognostic for MVD[4,8,21]. Quantitative 
sensory testing, electrophysiological and evoked potentials studies can also assist in identifying 
symptomatic TN, though it is not used routinely[3,4,21]. Classical TN has to be differentiated from other 
possible reasons why a patient presents with trigeminal nerve can become compressed or damaged[4,8,21]. 
Neuralgia pain is not always indicative of TN as other causes may give rise to neuralgia pain. A thorough 
examination and radiological investigation is vital in the identification of the cause of pain and is almost 
entirely based on the patient’s history and generally, no specific laboratory tests are needed[4,11,29]. A good 
history and clinical examination are paramount to the diagnosis of TN which has to be differentiated 
from other possible reasons why a patient presents with orofacial pain and headaches[11,12,21]. When 
reaching a diagnosis and treatment plan for TN, it is important to consider other possible causes of 
damage or compression of the trigeminal nerve, such as a tumour, a cyst, arteriovenous malformation, 
physical damage to the nerve due to trauma, a dental or surgical treatment, or infection[11,12,21]. Another 
consideration is multiple sclerosis a long-term condition that affects the nervous system due to 
demyelization of the nerve[4,29,30], however in most cases of classical TN the pain is predominately associated 
with compression of the trigeminal nerve by the superior cerebella artery[21,30].
This case highlights a case of persistent breakthrough symptoms of TN which required a good diagnosis, 
patient education and follow up strategy. The remarkably positive outcome attained, despite the severity 
of the symptoms and non-responsiveness to medication highlights the importance of individualizing the 
management plan according to the patient’s circumstances and the need for a holistic team approach to 
patient treatment. 
TN is one of the most debilitating diseases an individual may suffer and an astute diagnosis of TN will 
save some patients from suffering, unnecessary dental and medical treatments. MVD being a conservative 
method can be considered the gold standard and in the field of surgery MVD can be considered a safe and 
effective treatment for patients with typical TN that are not responsive to pharmacological therapy and 
are good candidates for surgery. After a successful MVD, many patients awaken without pain and remain 
pain-free while in other cases the pain resolves gradually during the week or two after operation. This case 
underlines the value of adequately educating caregivers about facial pain and appropriate referrals, which 
is in the best interest of the patient.
In conclusion, the originality of the present case rests on the fact that despite the severity of the symptoms 
and non-responsiveness to medication, a remarkably positive outcome was attained. This presents a 
strong case for MVD intervention particularly where a high-resolution MRI clearly demonstrates vascular 
compression. MVD should be considered as the first surgical choice when the patient’s conditions 
are satisfactory though it is essential that high-quality evidence that compares different modalities of 
treatments is available to provide a reliable and balanced selection of high-quality evidence that can enable 
patients, physicians, and health policy makers to select the most effective and efficient treatment.
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